Skip to content
healthcare.dev

Carglumic acid

NDC 68475-006, Carglumic acid, tablet, for suspension, from Navinta LLC.

Product NDC
68475-006
Status
Listed
Labeler
Navinta LLC
Dosage form
TABLET, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213395
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68475-006 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CARGLUMIC ACID200 mg/1

Pharmacologic classes

Carbamoyl Phosphate Synthetase 1 Activator [EPC]; Carbamoyl Phosphate Synthetase 1 Activators [MoA]

Package NDCNDC-11Package
68475-006-01684750006015 TABLET, FOR SUSPENSION in 1 BOTTLE (68475-006-01)
68475-006-026847500060260 TABLET, FOR SUSPENSION in 1 BOTTLE (68475-006-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/59e73eb8-edf8-4fad-93c2-deb6b23497f8

Use it

Look up 68475-006 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68475-006 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68475-006. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.